Journal of Population Therapeutics & Clinical Pharmacology

This article reports on the assessment of favipiravir-induced liver injury by evaluating liver enzymes among 66 patients in Iraq with mild to moderate COVID-19 infection and who were treated with favipiravir for 5 days.

Journal Article